Hu­man Longevi­ty makes a move to­ward Nas­daq with po­ten­tial SPAC deal, but noth­ing's fi­nal yet

An­ti-ag­ing com­pa­ny Hu­man Longevi­ty, found­ed by pi­o­neer­ing ge­nom­ic re­searcher Craig Ven­ter, is one step clos­er, po­ten­tial­ly, to be­com­ing a pub­lic com­pa­ny.

The start­up put out …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER